Abstract
Background Anxiety and depression are common, debilitating and costly. These disorders are influenced by multiple risk factors, from genes to psychological vulnerabilities and environmental stressors but research is hampered by a lack of sufficiently large comprehensive studies. We are recruiting 40,000 individuals with lifetime depression or anxiety, with broad assessment of risks to facilitate future research.
Methods The Genetic Links to Anxiety and Depression (GLAD) Study (www.gladstudy.org.uk) recruits individuals with depression or anxiety into the NIHR Mental Health BioResource. Participants invited to join the study (via media campaigns) provide demographic, environmental and genetic data, and consent for medical record linkage and recontact.
Results Online recruitment was effective; 41,892 consented and 26,877 participants completed the questionnaire by July 2019. Participants’ questionnaire data identified very high rates recurrent depression, severe anxiety and comorbidity. Participants reported high rates of treatment receipt. The age profile of sample is biased toward young adults, with higher recruitment of females and the better educated, especially at younger ages.
Discussion This paper describes the study methodology and descriptive data for GLAD, which represents a large, recontactable resource that will enable future research into risks, outcomes and treatment for anxiety and depression.
Highlights
Online recruitment of 40,000 individuals with lifetime depression or anxiety (77 characters)
Detailed online phenotyping combined with genetic and clinical data (66 characters)
The study sample is severe, highly comorbid, with chronic psychopathology (62 characters)
The study protocol enables recall of participants for future research and trials (82 characters)
HighlightsThe views expressed are those of the authors and not necessarily those of the NHS, NIHR, Department of Health or King’s College London
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
UK NIHR
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
↵* Joint senior authors
Declaration of Interests: Dr Breen has received honoraria, research or conference grants and consulting fees from Eli Lilly, Illumina and Otsuka. Prof Eley and Dr Breen are part-funded by a program grant from the UK Medical Research Council (MR/M021475/1). Prof Cleare has in the last three years received honoraria, travel funding, or consultancy fees from Lundbeck, Livanova, and Janssen.
Funding: This work was supported by the National Institute of Health Biomedical Research Centre [IS-BRC-1215-20018].
Data Availability
This is a cohort description paper.
Abbreviations
- SNP
- single nucleotide polymorphism
- GLAD
- Genetic Links to Anxiety and Depression
- NIHR
- National Institute for Health Research
- IAPT
- Improving Access to Psychological Therapies
- SLaM
- South London and Maudsley
- NHS
- National Health Service
- SURE
- Service User Research Enterprise
- FAST-R
- Feasibility and Acceptability Support Team for Researchers
- PR
- public relations
- SOPs
- standard operating procedures
- CRN
- Clinical Research Networks
- GP
- general practitioner
- CCG
- Clinical Commissioning Group
